Fig. 2From: Liraglutide treatment is associated with progression of coronary artery fibrous plaque: a prospective 1-year follow-up study in asymptomatic patients with type 2 diabetesNormalized plaque volumes of dense calcium, fibrous, fibrous-fatty, and necrotic core plaque during 1-year follow-up in patients treated with liraglutide (Lira+) and patients not treated with liraglutide (Lira-)Back to article page